denosumab
amgen,daiichi sankyo
['denosumab']
rx for v high risk pts: anabolics teriparatide: vert/nonvert fx (nejm 2001)
abaloparatide: active/activextend
- sustained vert+nonvert fx risk reduction romosozumab: frame
- romo v pbo followed by denosumab
- romo vert+nonvert fx risk reduction&gt;pbo
#acr22 #acramabassador
(pronounced VUH-neet sun-dhoo) Mother. She/Her/Hers. Rheumatologist. Program Director @lluhealth. Tweets are not medical advice. #ACRAmbassador @lluhphysicians